Financhill
Back

Ultragenyx Pharmaceutical Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
54.41
Seasonality Move:
7.55%
Sell
49

NBY
NovaBay Pharmaceuticals

Last Price:
0.70
Seasonality Move:
-22.66%
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.43
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 43.18 Sell
Chaikin Money Flow: -435004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.76 - 58.26) Sell
Bollinger Bands (100): (40.14 - 54.08) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.14 Buy
Chaikin Money Flow: 63291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.44 - 0.64) Buy
Bollinger Bands (100): (0.44 - 3.24) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.08 Sell
20-day SMA: 56.96 Sell
50-day SMA: 52.99 Buy
200-day SMA: 46.88 Buy
8-day EMA: 56.5 Sell
20-day EMA: 56.46 Sell
50-day EMA: 53.4 Buy
200-day EMA: 47.32 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Buy
20-day SMA: 0.55 Buy
50-day SMA: 0.69 Buy
200-day SMA: 3.51 Sell
8-day EMA: 0.67 Buy
20-day EMA: 0.61 Buy
50-day EMA: 0.9 Sell
200-day EMA: 7.9 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):